Ditchcarbon
  • Contact
  1. Organizations
  2. Beigene
Public Profile
Pharmaceutical Preparation Manufacturing
CN
updated a month ago

Beigene Sustainability Profile

Company website

Beigene, a leading biotechnology company headquartered in China (CN), is at the forefront of developing innovative therapies for cancer and other serious diseases. Founded in 2010, Beigene has rapidly expanded its operations across major regions, including North America, Europe, and Asia, establishing a strong global presence in the biopharmaceutical industry. The company is renowned for its robust pipeline of targeted therapies and immuno-oncology products, with a focus on precision medicine. Notable achievements include the successful development of its flagship drug, Brukinsa, which has gained recognition for its efficacy in treating various forms of blood cancer. Beigene's commitment to research and development, coupled with strategic partnerships, positions it as a key player in the competitive landscape of oncology therapeutics.

DitchCarbon Score

How does Beigene's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

49

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Beigene's score of 49 is higher than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.

67%

Let us know if this data was useful to you

Beigene's reported carbon emissions

In 2024, BeiGene reported total carbon emissions of approximately 755,827,000 kg CO2e. This figure includes Scope 1 emissions of about 3,547,000 kg CO2e, primarily from mobile combustion (1,908,000 kg CO2e) and stationary combustion (1,071,000 kg CO2e). Scope 2 emissions totalled around 89,591,000 kg CO2e, with purchased electricity contributing 60,556,000 kg CO2e. The most significant portion of emissions came from Scope 3, amounting to approximately 662,688,000 kg CO2e, largely driven by purchased goods and services (505,006,000 kg CO2e). In 2023, BeiGene's total emissions were about 555,892,000 kg CO2e, with Scope 1 emissions at 2,462,000 kg CO2e and Scope 2 emissions at 76,465,000 kg CO2e. The Scope 3 emissions for that year were approximately 476,965,000 kg CO2e. BeiGene has set ambitious climate commitments, aiming to reduce its Scope 1 and Scope 2 emissions to near zero by 2025. Additionally, the company targets a 30% reduction in Scope 1 and Scope 2 emissions by 2030 from a 2020 baseline. They also plan to reduce their Scope 1 and 2 emissions by 25% per unit of internally manufactured commercial products by 2026, using 2021 as a baseline. These commitments reflect BeiGene's proactive approach to addressing climate change and reducing its carbon footprint in the pharmaceutical industry.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2018201920202021202220232024
Scope 1
535,000
000,000
000,000
0,000,000
0,000,000
0,000,000
0,000,000
Scope 2
5,929,000
0,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 3
-
-
-
000,000,000
000,000,000
000,000,000
000,000,000

How Carbon Intensive is Beigene's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Beigene's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Beigene's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Beigene is in CN, which we do not have grid emissions data for.

Beigene's Scope 3 Categories Breakdown

Beigene's Scope 3 emissions, which increased by 39% last year and increased by approximately 132% since 2021, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 76% of Scope 3 emissions.

Top Scope 3 Categories

2024
Purchased Goods and Services
76%
Capital Goods
12%
Fuel and Energy Related Activities
4%
Business Travel
3%
Upstream Leased Assets
2%
Upstream Transportation & Distribution
2%
Employee Commuting
<1%
Investments
<1%
Waste Generated in Operations
<1%
End-of-Life Treatment of Sold Products
<1%

Beigene's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Beigene has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Beigene's Emissions with Industry Peers

Gilead Sciences

US
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Eli Lilly and Company

GB
•
Pharmaceutical Preparation Manufacturing
Updated about 19 hours ago

Novartis

CH
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Innocare Pharma

CN
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Abbvie

US
•
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

Glaxosmithkline

GB
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251030.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy